Showing 401 - 420 results of 1,139 for search '"preclinical"', query time: 0.05s Refine Results
  1. 401

    A Bayesian Markov Framework for Modeling Breast Cancer Progression by Tong Wu

    Published 2024-12-01
    “…This study develops a three-state Markov framework to estimate the transition rates between normal, preclinical screen-detectable phase (PCDP), and clinical breast cancer using simulated data. …”
    Get full text
    Article
  2. 402

    Thrombospondin-1: Multiple Paths to Inflammation by Zenaida Lopez-Dee, Kenneth Pidcock, Linda S. Gutierrez

    Published 2011-01-01
    “…The effects of TSP-1 have been studied in many preclinical tumor models, and mimetic peptides are being tested in cancer clinical trials. …”
    Get full text
    Article
  3. 403

    When molecular biology transforms clinical oncology: the EGFR journey in colorectal cancer by Pietro Paolo Vitiello, Nadia Saoudi González, Alberto Bardelli

    Published 2025-02-01
    “…The discovery of growth factors and their involvement in cancer represents the foundation of precision oncology. The preclinical and clinical development of agents targeting epidermal growth factor receptor (EGFR) in colorectal cancer (CRC) were accompanied by big hype and hopes, though the clinical testing of such agents clashed with intrinsic and acquired resistance, greatly limiting their therapeutic value. …”
    Get full text
    Article
  4. 404

    Statins in Asthma: Potential Beneficial Effects and Limitations by Dipanjan Bhattacharjee, Bharti Chogtu, Rahul Magazine

    Published 2015-01-01
    “…However, the initial excellent results from the preclinical and animal studies have not borne the results in clinical trials that the scientific world was hoping for. …”
    Get full text
    Article
  5. 405

    Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma by Andrea Emanuele Guerini, MD, Eneida Mataj, MD, Paolo Borghetti, MD, Luca Triggiani, Ludovica Pegurri, MD, Stefania Nici, Stefano Riga, Alessandra Tucci, MD, Angelo Belotti, MD, Marco Lorenzo Bonù, MD, Giorgio Facheris, MD, Stefano Maria Magrini, Luigi Spiazzi, Michela Buglione

    Published 2025-03-01
    “…Purpose: Multiple myeloma (MM) tends to develop resistance to systemic therapy through multiple mechanisms that might as well induce radioresistance, as suggested by preclinical studies. The aim of the present analysis was to elucidate whether the number of systemic treatment lines received prior to radiation therapy (RT) might confer radioresistance and influence local response. …”
    Get full text
    Article
  6. 406
  7. 407

    Advanced 3D bioprinted liver models with human-induced hepatocytes for personalized toxicity screening by Yue Ma, Runbang He, Bo Deng, Miaomiao Luo, Wenjie Zhang, Lina Mao, Wenxiang Hu, Yilei Mao, Huayu Yang, Pengyu Huang

    Published 2025-01-01
    “…The development of advanced in vitro models for assessing liver toxicity and drug responses is crucial for personalized medicine and preclinical drug development. 3D bioprinting technology provides opportunities to create human liver models that are suitable for conducting high-throughput screening for liver toxicity. …”
    Get full text
    Article
  8. 408
  9. 409
  10. 410
  11. 411

    Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins by Gerd Bendas, Lubor Borsig

    Published 2012-01-01
    “…Clinical evidence indicates that heparin, commonly used for treatment of thromboembolic events in cancer patients, is beneficial for their survival. Preclinical studies confirm that heparin possesses antimetastatic activities that lead to attenuation of metastasis in various animal models. …”
    Get full text
    Article
  12. 412

    Bidirectional causality of physical exercise in retinal neuroprotection by Stephen K. Agadagba, Suk-yu Yau, Ying Liang, Kristine Dalton, Benjamin Thompson

    Published 2025-12-01
    “…Finally, we discuss future directions for preclinical and clinical research in exercise and eye health.…”
    Get full text
    Article
  13. 413
  14. 414

    Bacteria in Cancer Therapy: Renaissance of an Old Concept by Sebastian Felgner, Dino Kocijancic, Michael Frahm, Siegfried Weiss

    Published 2016-01-01
    “…This review summarizes and compares the results of the past 150 years in bacteria mediated tumor therapy from preclinical to clinical studies. Lessons we have learned from the past provide a solid foundation on which to base future efforts. …”
    Get full text
    Article
  15. 415

    Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias by Hagai Yavin, Mark Prasad, Jonathan Gordon, Tolga Aksu, Henry D. Huang

    Published 2024-12-01
    “…In this review, we discuss the available preclinical and clinical evidence for PFA for atrial fibrillation, developments for ventricular arrhythmia (VA) ablation, and future perspectives.…”
    Get full text
    Article
  16. 416

    Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer’s Disease by Kyeong-Ah Kwak, Seung-Pyo Lee, Jin-Young Yang, Young-Seok Park

    Published 2018-01-01
    “…The results from recent preclinical studies regarding stem cell-based therapies are promising. …”
    Get full text
    Article
  17. 417

    Toxicological Review of Anticancer Plants Used in Traditional Medicine in Morocco by Soufiane Drioua, Abha Cherkani-Hassani, Otman El-Guourrami, Mouna Ameggouz, Ahmed Zahidi, Abdelhakim Bouyahaya, Sayyed Ibrahim Shah, Yaser Mohammed Al-Worafi, Long Chiau Ming, Hanane Benzaied, Anass Doukkali

    Published 2023-05-01
    “…Further research, including preclinical and clinical trials, should be conducted to investigate the potential therapeutic benefits of these plants. …”
    Get full text
    Article
  18. 418

    Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice by Melissa Medeiros Markoski

    Published 2016-01-01
    “…Knowledge about how adult stem cells modulate the molecular signals to activate cell homing has also been increasingly determined, evidencing the mechanisms which enable cells to repair and regenerate injured tissues. Preclinical studies were designed for many animal models and they have contributed to the translation to the human clinic. …”
    Get full text
    Article
  19. 419

    Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease by Allison P. Watson, Claudio G. Brunstein, Shernan G. Holtan

    Published 2018-01-01
    “…Ruxolitinib is an oral selective Janus-associated kinase 1 (JAK1) and JAK2 inhibitor that was initially approved by the FDA in 2014 for treatment of myelofibrosis. In preclinical and retrospective clinical studies, use of ruxolitinib was shown to reduce graft-versus-host-disease (GVHD) in allograft recipients with moderate/severe corticosteroid-dependent or refractory chronic GVHD. …”
    Get full text
    Article
  20. 420

    CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms by Raanan Greenman, Chris J. Weston

    Published 2025-01-01
    “…This review delves into the intricate role of CCL24 in fibrotic diseases, highlighting its impact on fibrotic, immune, and vascular pathways. We focus on the preclinical and clinical evidence supporting the therapeutic potential of blocking CCL24 in diseases that involve excessive inflammation and fibrosis.…”
    Get full text
    Article